Send us Feedback

Achillion Pharmaceuticals (ACHN)
Analysis
SUMMARY
BULLS
BEARS
TOPICS
Data
DATA CENTRAL
STOCK CHART
Financials
SEC FILINGS
BALANCE
INCOME
CASH FLOW
 
 
 
 
⟩





⟩





⟩





⟩





⟩





⟩





⟩
Balance Sheet    (USD)
Annual | Quarterly
QUARTER ENDING 31-MAR
2012		 30-JUN
2012		 30-SEP
2012		 31-DEC
2012		 31-MAR
2013
Cash & Equivalents 29.5M 18.3M 20.8M 18.5M 39.4M
Short Term Investments 35.1M 41.7M 60.1M 46.9M 106M
Accounts Receivable 17.0K 426K 463K 277K 589K
Inventories 0 0 0 0 0
Pre-paid Expenses 2.38M 1.94M 2.29M 2.18M 3.77M
Deferred Tax Assets 0 0 0 0 0
Other Current Assets 0 0 0 0 0
Total Current Assets 67.0M 62.3M 83.7M 67.9M 149M
Property, Plant & Equipment 1.37M 1.36M 1.31M 1.25M 1.30M
Goodwill & Intangibles 0 0 0 0 0
Other Long-term Assets 5.62M 164K 9.90M 12.4M 55.2M
Total Long-Term Assets 6.99M 1.53M 11.2M 13.7M 56.5M
Total Assets 74.0M 63.8M 94.9M 81.5M 206M
Accounts Payable 4.90M 4.87M 5.87M 4.28M 5.19M
Accrued Expenses 0 0 0 0 0
Short Term Debt 333K 339K 345K 350K 356K
Other Current Liabilities 0 0 0 0 0
Total Current Liabilities 9.40M 9.93M 12.8M 9.14M 10.6M
Long Term Debt 611K 524K 436K 347K 255K
Capital Lease Obligations 0 0 0 0 0
Deferred Income Tax 0 0 0 0 0
Other Long-term Liabilities 0 0 0 0 0
Total Long-term Liabilities 611K 524K 436K 347K 255K
Minority Interest 0 0 0 0 0
Total Liabilities 10.0M 10.5M 13.2M 9.48M 10.8M
Preferred Stock 0 0 0 0 0
Common Par 71.0K 72.0K 80.0K 80.0K 97.0K
Additional Paid-In Capital 349M 350M 393M 395M 529M
Retained Earnings -285M -296M -312M -323M -334M
Treasury Stock 0 0 0 0 0
Other Equity 28.0K 12.0K 45.0K 19.0K -31.0K
Total Shareholder's Equity 64.0M 53.4M 81.7M 72.0M 195M
⟩





⟩





⟩





⟩





⟩





⟩





⟩
 
⟩





⟩





⟩





⟩





⟩





⟩





⟩
 
⟩





⟩





⟩





⟩





⟩





⟩





⟩
 
⟩





⟩





⟩





⟩





⟩





⟩





⟩
Data Sources:
Market and financial statement data provided by NASDAQ, BATS Exchange, SEC and Xignite Inc. Industry and operating metrics collected from company filings via EDGAR online. For more information on sources and calculations click here.
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki